Log in

NYSEAMERICAN:INFUInfuSystem Stock Price, Forecast & News

$13.87
+1.34 (+10.69 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.58
Now: $13.87
$14.19
50-Day Range N/A
52-Week Range
$4.30
Now: $13.87
$14.19
Volume296,726 shs
Average Volume101,065 shs
Market Capitalization$278.37 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.96 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees237
Market Cap$278.37 million
Next Earnings Date8/13/2020 (Confirmed)
OptionableNot Optionable
$13.87
+1.34 (+10.69 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InfuSystem?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for InfuSystem
.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for InfuSystem
.

How can I listen to InfuSystem's earnings call?

InfuSystem will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) issued its earnings results on Thursday, May, 14th. The medical instruments supplier reported ($0.02) EPS for the quarter. The medical instruments supplier earned $21.55 million during the quarter.
View InfuSystem's earnings history
.

What price target have analysts set for INFU?

1 equities research analysts have issued twelve-month price objectives for InfuSystem's stock. Their forecasts range from $17.00 to $17.00. On average, they expect InfuSystem's share price to reach $17.00 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts' price targets for InfuSystem
.

Has InfuSystem been receiving favorable news coverage?

Headlines about INFU stock have been trending very negative this week, InfoTrie reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InfuSystem earned a media sentiment score of -3.4 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about InfuSystem
.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by many different retail and institutional investors. Top institutional investors include UBS Group AG (0.31%), Mackay Shields LLC (0.20%), Virtu Financial LLC (0.07%), New York State Common Retirement Fund (0.07%) and Strs Ohio (0.02%). Company insiders that own InfuSystem stock include Awm Investment Company, Inc, Barry G Steele, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Ronald H Jr Peele, Scott Shuda, Terry L Armstrong and Thomas Mark Ruiz.
View institutional ownership trends for InfuSystem
.

Which major investors are buying InfuSystem stock?

INFU stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Virtu Financial LLC, New York State Common Retirement Fund, and Strs Ohio. Company insiders that have bought InfuSystem stock in the last two years include Awm Investment Company, Inc, Barry G Steele, Christopher R Sansone, Jeannine Sheehan, Paul Andrew Gendron, Richard Dilorio, Ronald H Jr Peele, Scott Shuda, and Terry L Armstrong.
View insider buying and selling activity for InfuSystem
.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $13.87.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $278.37 million. InfuSystem employs 237 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.